PCOS Gets a New Name in Landmark Women's Health Shift
via HealthDayFRIDAY, May 15, 2026 — A major women’s health condition is getting a new name—and experts say it could change how millions are diagnosed and treated worldwide.
Polycystic ovary syndrome, or PCOS, will now be known as polyendocrine metabolic ovarian syndrome, or PMOS.
The condition affects more than 170 million women worldwide and is linked to hormone imbalances, weight and metabolic issues, mental health symptoms, skin changes and fertility challenges.
Experts said the old name was misleading because the condition is not actually defined by ovarian cysts.
"What we now know is that there is actually no increase in abnormal cysts on the ovary and the diverse features of the condition were often unappreciated," said Helena Teede, director of the Monash Center for Health Research & Implementation in Australia and an endocrinologist at Monash Health.
Researchers say the misunderstanding contributed to delayed diagnoses and inadequate care for many patients.
The renaming effort — documented in an article published May 12 in The Lancet — took 14 years. It involved more than 50 medical and patient advocacy organizations, along with more than 22,000 survey responses from people affected by the condition.
Patient advocate Rachel Morman, chair of Verity, a patient advocacy group that aims to raise awareness around PMOS, says the new name reflects the true complexity of the condition.
"This shift will reframe the conversation and demand that it is taken as seriously as the long-term, complex health condition it is," she said.
The new name will be rolled out globally over the next three years through a major education and awareness campaign.
Experts hope it will lead to earlier diagnoses, better treatment and improved long-term care for women around the world.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-16 02:24
Read more
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Cognitive-Behavioral Therapy May Aid Menopause Outcomes
- Polysubstance, Opioid-Related Overdose Deaths Rose From 2004 to 2022
- HRS: Atrial Arrhythmia Recurrence Lower in Persistent A-Fib With Pulsed Field Ablation Versus Antiarrhythmics
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- First Measles Case of the Year Reported in New Jersey
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions